Clarivate
MARCH 14, 2024
With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt. Impending change affords an opportunity for innovation.
Clarivate
NOVEMBER 17, 2021
In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. Subscribe to Conversations in Healthcare . In small organizations, in fact, regulatory affairs and regulatory intelligence are quite often, these functions are conducted by the same people.
pharmaphorum
SEPTEMBER 28, 2022
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.
Expert insights. Personalized for you.
52 
Let's personalize your content